Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) had its price target increased by equities researchers at Wells Fargo & Company from $21.00 to $23.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target indicates a potential upside of 11.80% from the stock’s current price.
Other research analysts have also recently issued research reports about the stock. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. Truist Financial upped their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Weiss Ratings raised Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a report on Tuesday, November 3rd. Mizuho set a $21.00 price target on Sabra Healthcare REIT in a report on Monday, August 31st. Finally, Citizens Jmp boosted their price target on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $21.83.
View Our Latest Report on Sabra Healthcare REIT
Sabra Healthcare REIT Trading Up 0.7%
Sabra Healthcare REIT stock opened at $20.57 on Monday. The business has a 50-day simple moving average of $19.88 and a two-hundred day simple moving average of $20.04. The company has a market cap of $5.39 billion, a P/E ratio of 74.36, a P/E/G ratio of 1.78 and a beta of 0.68. Sabra Healthcare REIT has a 52-week low of $17.53 and a 52-week high of $22.77. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.86.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.05). The business had revenue of $249.57 million for the quarter, compared to analysts’ expectations of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.55%. Sabra Healthcare REIT’s revenue for the quarter was up 31.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.38 EPS. Analysts predict that Sabra Healthcare REIT will post 1.52 EPS for the current year.
Insider Buying and Selling
In other Sabra Healthcare REIT news, Director Michael J. Foster sold 10,000 shares of the stock in a transaction on Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total value of $209,800.00. Following the completion of the sale, the director owned 72,834 shares in the company, valued at approximately $1,528,057.32. This represents a 12.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Richard K. Matros sold 200,000 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.09% of the company’s stock.
Hedge Funds Weigh In On Sabra Healthcare REIT
A number of hedge funds have recently made changes to their positions in the business. Cetera Investment Advisers grew its position in shares of Sabra Healthcare REIT by 0.8% during the third quarter. Cetera Investment Advisers now owns 172,023 shares of the real estate investment trust’s stock worth $3,392,000 after purchasing an additional 1,322 shares in the last quarter. EP Wealth Advisors LLC purchased a new position in Sabra Healthcare REIT in the 3rd quarter worth approximately $278,000. Pathstone Holdings LLC purchased a new position in Sabra Healthcare REIT in the 3rd quarter worth approximately $229,000. Empowered Funds LLC bought a new position in Sabra Healthcare REIT in the 3rd quarter worth approximately $600,000. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Sabra Healthcare REIT by 161.0% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 926,972 shares of the real estate investment trust’s stock worth $18,280,000 after purchasing an additional 571,743 shares during the period. Institutional investors own 99.40% of the company’s stock.
Sabra Healthcare REIT Company Profile
Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
